Who qualifies for Medicare GLP-1 weight loss drugs for $50 a month
Even with initial uncertainties, the research community is excited about the potential uses of GLP-1s for treating mental health
Omzo publishes a HIPAA Privacy Policy at omzo.com/hipaa-policy describing how protected health information is handled and covering patient rights with respect to protected health information, including the right to access, amend, and restrict disclosure of their PHI
FDA approves Ozempic for cardiovascular risk reduction in adults with type 2 diabetes and known heart disease, updates Rybelsus label [Press release], Novo Nordisk (2020) Safety of semaglutide, Frontiers in Endocrinology (2021) Ozempic label, Novo Nordisk (2023) Bruising: A neglected, though patient-relevant complication of insulin injections coming to light from a real-life nationwide survey, Diabetes Therapy (2021) Using your Ozempic pen, Novo Nordisk Effect of cold application on bruising and pain following Heparin subcutaneous injection: a systematic review and meta-analysis, Journal of Nursing Scholarship (2020) Effect of cold application and compression on pain and bruising in subcutaneous heparin injection, Journal of Vascular Nursing (2023) Oral semaglutide, Clinical Diabetes (2020) Daily oral GLP-1 receptor agonist orforglipron for adults with obesity, The New England Journal of Medicine (2023) Oral and injectable medications for Type 2 diabetes, American Diabetes Association Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity
Incorporate Beneficial Fats (Specifically MUFAs) The Science: For a long time, dietary fat was misunderstood in the context of satiety, but we now know that the type of fat you choose matters so much for hormonal signaling and health
